Cytokine release syndrome in a patient with non-small cell lung cancer on ipilimumab and nivolumab maintenance therapy after vaccination with the mRNA-1273 vaccine: a case report

BACKGROUND: Cytokine release syndrome (CRS) is caused by the release of inflammatory cytokines that appear during or immediately after administration of a therapeutic antibody and can cause a variety of symptoms. COVID-19 vaccination is effective in cancer patients and prevents breakthrough infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumi, Toshiyuki, Koshino, Yuta, Michimata, Haruhiko, Nagayama, Daiki, Watanabe, Hiroki, Yamada, Yuichi, Chiba, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554683/
https://www.ncbi.nlm.nih.gov/pubmed/36248324
http://dx.doi.org/10.21037/tlcr-22-388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554683/
https://www.ncbi.nlm.nih.gov/pubmed/36248324
http://dx.doi.org/10.21037/tlcr-22-388

Ejemplares similares